Page last updated: 2024-09-03

y 27632 and atrial natriuretic factor

y 27632 has been researched along with atrial natriuretic factor in 2 studies

Compound Research Comparison

Studies (y 27632)	Trials (y 27632)	Recent Studies (post-2010) (y 27632)	Studies (atrial natriuretic factor)	Trials (atrial natriuretic factor)	Recent Studies (post-2010) (atrial natriuretic factor)
1,924	3	891	15,455	1,105	1,760

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamanaka, I; Harada, M; Izumi, T; Kajiyama, N; Kawakami, R; Kishimoto, I; Kuwahara, K; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Ogawa, Y; Saito, Y; Takahashi, N; Tamura, N	1
Akimoto, K; Asakawa, H; Horio, T; Matsuoka, H; Minamino, N; Mori, Y; Nishikimi, T; Tadokoro, K; Wang, X; Yoshihara, F	1

Other Studies

2 other study(ies) available for y 27632 and atrial natriuretic factor

Article	Year
The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes--possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS letters, 1999, Jun-11, Volume: 452, Issue:3 Topics: Amides; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Endothelin-1; Enzyme Inhibitors; GTP Phosphohydrolases; Heart; Humans; Intracellular Signaling Peptides and Proteins; Kinetics; Myocardium; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Pyridines; Rats; Recombinant Proteins; rho-Associated Kinases; Time Factors; Transfection	1999
Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin. European journal of pharmacology, 2002, Oct-25, Volume: 453, Issue:2-3 Topics: ADP Ribose Transferases; Amides; Animals; Atrial Natriuretic Factor; Botulinum Toxins; Cell Size; Cells, Cultured; Endothelin-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Mevalonic Acid; Myocytes, Cardiac; Phenylalanine; Polyisoprenyl Phosphates; Pravastatin; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger	2002

Article

Year

The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes--possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy.

FEBS letters, 1999, Jun-11, Volume: 452, Issue:3

Topics: Amides; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Endothelin-1; Enzyme Inhibitors; GTP Phosphohydrolases; Heart; Humans; Intracellular Signaling Peptides and Proteins; Kinetics; Myocardium; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Pyridines; Rats; Recombinant Proteins; rho-Associated Kinases; Time Factors; Transfection

1999

Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin.

European journal of pharmacology, 2002, Oct-25, Volume: 453, Issue:2-3

Topics: ADP Ribose Transferases; Amides; Animals; Atrial Natriuretic Factor; Botulinum Toxins; Cell Size; Cells, Cultured; Endothelin-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Mevalonic Acid; Myocytes, Cardiac; Phenylalanine; Polyisoprenyl Phosphates; Pravastatin; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger

2002